This statistic shows the percent approval for NDA/BLA filings for new drugs in the U.S., within the period from January 1, 2006 to December 31, 2015, by disease area. It was found that 79 percent of oncology drugs were approved by the FDA on first review, compared to just 37 percent of psychiatry drugs.
Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization, & BioMedTracker, & Amplion. (May 25, 2016). Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/597755/nda-bla-filing-approval-new-drugs-us/
Biotechnology Innovation Organization, und BioMedTracker, und Amplion. "Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015." Chart. May 25, 2016. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/597755/nda-bla-filing-approval-new-drugs-us/
Biotechnology Innovation Organization, BioMedTracker, Amplion. (2016). Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/597755/nda-bla-filing-approval-new-drugs-us/
Biotechnology Innovation Organization, and BioMedTracker, and Amplion. "Percent Approval for Nda/Bla Filings for New Drugs in Select Disease Areas in The U.S. between 2006 and 2015." Statista, Statista Inc., 25 May 2016, https://www-statista-com.ezproxy.canberra.edu.au/statistics/597755/nda-bla-filing-approval-new-drugs-us/
Biotechnology Innovation Organization & BioMedTracker & Amplion, Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/597755/nda-bla-filing-approval-new-drugs-us/ (last visited November 10, 2024)
Percent approval for NDA/BLA filings for new drugs in select disease areas in the U.S. between 2006 and 2015 [Graph], Biotechnology Innovation Organization, & BioMedTracker, & Amplion, May 25, 2016. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/597755/nda-bla-filing-approval-new-drugs-us/
